In our previous studies, we observed that ATQ significantly suppressed the primary and paclitaxel resistant breast tumor growth by inhibiting HER2/β-catenin/c-Myc signaling, supporting our rationale for the current investigation [40]. Here, ERBB2 is linked to breast neoplasm.